Skip to main content
. 2020 May 19;8(2):236. doi: 10.3390/vaccines8020236

Figure 4.

Figure 4

Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) vaccine variety, adapted from Callaway (2020), pp. 576–577.